Never Run Out Of Buyers To Sell To.

BioPerfectus (SSE: 688399) stands at the forefront of the molecular diagnostics industry, with a specialization in "diagnostics for infectious diseases and women's and children's health". Founded in 2010, BioPerfectus consistently emphasizes R&D, manufacturing, and the distribution of in-vitro diagnostic reagents and instruments. Through strategic planning, the company has seamlessly integrated its efforts from the development and production of upstream core materials to downstream diagnostic services. With a diverse portfolio of over 600 products, BioPerfectus caters to a broad spectrum of…
Built from contact records that share this company: name, job title, job level, job function and person location.
Turn cold outreach into meaningful business conversations.
Rated and recommended by professionals who expect more
Annual Revenue$250M to $500M
Estimated OwnershipPrivateMatching runs on fields we already have: industry, employee range, HQ location, ownership type, funding rounds, specialities. Results come live from the ReachStream directory.